サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1455670

リラグルチド市場：用途別、流通別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024-2032年

Liraglutide Market, By Application, By Distribution, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 301 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.42円
リラグルチド市場：用途別、流通別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024-2032年
出版日: 2024年03月04日
発行: AnalystView Market Insights
ページ情報: 英文 301 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

リラグルチド市場規模は2023年に89億8,234万米ドルとなり、2024年から2032年にかけて11.34%のCAGRで拡大

リラグルチド市場- 市場力学

肥満と座りがちなライフスタイルに対する意識の高まりが市場需要を促進

リラグルチド市場は、時間の経過とともに糖尿病人口の緩やかな増加をもたらしている肥満と座りがちなライフスタイルの割合の増加により、大きな成長が見込まれています。さらに、不適切な食習慣や糖尿病疾患の根本的な蔓延もこの動向に寄与しています。さらに、研究開発への投資の増加は、技術の進歩や新製品の導入と相まって、予測期間におけるGLP-1アゴニストの市場拡大に有望な機会を提示しています。

リラグルチド市場-主要インサイト

弊社リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）において約11.34%のCAGRで毎年成長すると予測されています。

流通チャネルのセグメンテーションに基づいて、小売薬局・ドラッグストアは、2023年に最大の市場シェアを示すと予測されました。

用途別では、2023年に糖尿病治療が主要タイプに

地域別では、北米が2023年に主要な収益源となった

リラグルチド市場-セグメンテーション分析：

リラグルチドの世界市場は、用途、流通、地域に基づいてセグメント化されます。

市場は流通チャネルに基づいて3つのカテゴリーに分けられる：病院薬局、小売薬局・ドラッグストア、オンライン薬局です。2023年の流通チャネルは小売薬局とドラッグストアが支配的です。このチャネルは、リラグルチドを求める患者に利便性とアクセスしやすさを提供し、薬を入手するための一般的な選択肢となっています。特に病院内で治療を受けている患者には病院薬局が重要な役割を果たすかもしれないが、小売薬局・ドラッグストアが提供する幅広いアクセシビリティが、より高い販売量と市場浸透をもたらすことが多いです。オンライン薬局も、特にオンラインでの注文や配達の利便性を好む患者にとっては、流通に貢献するかもしれないです。しかし、小売薬局・ドラッグストアは通常、より確立された存在感を示しているため、より大きな市場シェアを握っている可能性があります。

市場は用途によって2つのカテゴリーに分けられる：糖尿病治療と体重管理です。リラグルチド市場の中で、糖尿病治療は2023年に注目すべき地位を占めています。リラグルチドは、主に2型糖尿病の管理に処方される薬剤で、グルカゴン様ペプチド-1（GLP-1）受容体作動薬として機能し、インスリン分泌を刺激し、グルカゴン放出を抑制し、胃排出を遅延させることで血糖値を効果的に調整します。血糖コントロールにおけるその有効性は、体重減少や心血管リスクの軽減といった付随的な利点と相まって、リラグルチドを糖尿病管理の礎となる治療薬として確立しています。その結果、糖尿病治療分野では、血糖目標値を達成し、糖尿病関連合併症のリスクを効果的に軽減しようと努める医療プロバイダーや患者から大きな需要が寄せられています。

リラグルチド市場-地理的洞察

リラグルチド市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの各地域に広く分布しています。これらの地域は、ビジネスをもたらす国ごとにさらに分けられます。

リラグルチド市場-競合情勢：

リラグルチド市場において、企業は需要の増加に対応し、患者の転帰を向上させるために様々な戦略を展開しています。これらの戦略には、リラグルチドの有効性を高め、患者の利便性を向上させることを目的として、リラグルチドの製剤や投与方法の改良を目的とした継続的な研究開発イニシアチブが含まれます。さらに、リラグルチドの心血管系リスクの軽減や非アルコール性脂肪性肝疾患の治療における潜在的な役割など、リラグルチドの新たな適応を検討するための臨床試験の実施にリソースを割いています。さらに、マーケティング活動では、医療従事者や患者への認知度向上に注力し、より広範な採用と市場浸透を目指しています。

目次

第1章 リラグルチド市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 リラグルチドの主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 リラグルチド産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 リラグルチド市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 リラグルチド市場情勢

  • リラグルチド市場シェア分析、2023年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 リラグルチド市場- 用途別

  • 概要
    • 用途別のセグメントシェア分析
    • 糖尿病治療
    • 体重管理

第8章 リラグルチド市場- 流通別

  • 概要
    • 流通別のセグメントシェア分析
    • 病院薬局
    • 小売薬局・ドラッグストア
    • オンライン薬局

第9章 リラグルチド市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東とアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析- リラグルチド産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Bachem
    • HEC Pharm
    • Kingpep Biotechnology
    • Shenzhen JYMed Technology
    • Novo Nordisk
    • Eli Lilly and Company
    • Boehringer Ingelheim
    • AstraZeneca
    • Others

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Liraglutide Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Liraglutide Market, by Application 2019-2032 (USD Million)
  • TABLE Liraglutide Market: Distribution Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution
  • TABLE Global Liraglutide Market, by Distribution 2019-2032 (USD Million)
  • TABLE Liraglutide Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Liraglutide Market, by Region 2019-2032 (USD Million)
  • TABLE North America Liraglutide Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Liraglutide Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Liraglutide Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Europe Liraglutide Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Liraglutide Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Liraglutide Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Asia Pacific Liraglutide Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Liraglutide Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Liraglutide Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Latin America Liraglutide Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Liraglutide Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Liraglutide Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Liraglutide Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Liraglutide Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Liraglutide Market, by Distribution, 2019-2032 (USD Million)
目次
Product Code: ANV2333

REPORT HIGHLIGHT

Liraglutide Market size was valued at USD 8,982.34 Million in 2023, expanding at a CAGR of 11.34% from 2024 to 2032.

Liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, serves as a treatment for type-2 diabetes and chronic obesity. It becomes necessary when diet and exercise alone fail to adequately control blood sugar levels. Typically employed as a second-line therapy for diabetes, following initial treatment with metformin, liraglutide is also utilized to mitigate the risk of heart and blood vessel complications, including heart attacks and strokes, in individuals with type-2 diabetes and pre-existing heart or blood vessel conditions. Marketed under the brand names Victoza and Saxenda, liraglutide addresses critical health concerns in diabetic and obese populations.

Liraglutide Market- Market Dynamics

Increasing awareness rates of obesity and sedentary lifestyles, to propel market demand

The Liraglutide for this market is expected to witness significant growth driven by escalating rates of obesity and sedentary lifestyles, which have led to a gradual increase in the diabetic population over time. Additionally, improper dietary habits and the underlying prevalence of diabetes disorders contribute to this trend. Furthermore, increased investment in research and development, coupled with technological advancements and the introduction of new products, present promising opportunities for the expansion of GLP-1 agonists in the market over the forecast period.

Liraglutide Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.34% over the forecast period (2024-2032)

Based on distribution channel segmentation, retail pharmacies and drug stores was predicted to show maximum market share in the year 2023

Based on application segmentation, Diabetes Treatment was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Liraglutide Market- Segmentation Analysis:

The Global Liraglutide Market is segmented on the basis of Application, Distribution, and Region.

The market is divided into three categories based on distribution channel: Hospital Pharmacies, Retail Pharmacies & Drug Stores and Online Pharmacies. The dominant distribution channel is retail pharmacies and drug stores in 2023. This channel offers convenience and accessibility to patients seeking liraglutide, making it a popular choice for obtaining medications. While hospital pharmacies may play a significant role, especially for patients receiving treatment within hospital settings, the broader accessibility provided by retail pharmacies and drug stores often results in higher sales volume and market penetration. Online pharmacies may also contribute to distribution, particularly for patients preferring the convenience of online ordering and delivery. However, retail pharmacies and drug stores typically have a more established presence and may therefore hold a larger share of the market.

The market is divided into two categories based on application: Diabetes Treatment and Weight Management. Within the liraglutide market, the diabetes treatment holds a notable position in 2023. Liraglutide, a medication predominantly prescribed for managing type 2 diabetes, functions as a glucagon-like peptide-1 (GLP-1) receptor agonist, effectively regulating blood sugar levels by stimulating insulin secretion, suppressing glucagon release, and delaying gastric emptying. Its effectiveness in glycemic control, combined with ancillary benefits such as weight reduction and mitigating cardiovascular risks, establishes liraglutide as a cornerstone therapy for diabetes management. As a result, the diabetes treatment segment experiences substantial demand from healthcare providers and patients striving to attain glycemic targets and mitigate the risk of diabetes-related complications effectively.

Liraglutide Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Liraglutide Market- Competitive Landscape:

In the Liraglutide market, companies are deploying varied strategies to address increasing demand and enhance patient outcomes. These strategies encompass ongoing research and development initiatives aimed at refining the formulation and delivery methods of liraglutide, with the goal of enhancing its effectiveness and improving patient convenience. Moreover, companies are allocating resources to conduct clinical trials to investigate new indications for liraglutide, such as its potential role in reducing cardiovascular risks and treating non-alcoholic fatty liver disease. Additionally, marketing efforts are focused on raising awareness among healthcare professionals and patients alike, aiming to foster broader adoption and market penetration.

Recent Developments:

In October 2023, Biocon, a global biopharmaceutical company, unveiled a collaboration with Juno Pharmaceuticals, a specialty pharmaceutical company headquartered in Canada, to commercialize Liraglutide, a drug-device combination designed for the treatment and management of type-2 diabetes and obesity within the Canadian market. Per the terms of the agreement, Biocon will undertake the responsibility of obtaining government approvals for Liraglutide and subsequently oversee its manufacturing and distribution throughout Canada.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIRAGLUTIDE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Bachem

HEC Pharm

Kingpep Biotechnology

Shenzhen JYMed Technology

Novo Nordisk

Eli Lilly and Company

Boehringer Ingelheim

AstraZeneca

Others

GLOBAL LIRAGLUTIDE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Diabetes Treatment
  • Weight Management

GLOBAL LIRAGLUTIDE MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Retail Pharmacies & Drug Stores
  • Online Pharmacies

GLOBAL LIRAGLUTIDE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Liraglutide Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Liraglutide Market Snippet by Application
    • 2.1.2.Liraglutide Market Snippet by Distribution
    • 2.1.3.Liraglutide Market Snippet by Country
    • 2.1.4.Liraglutide Market Snippet by Region
  • 2.2.Competitive Insights

3.Liraglutide Key Market Trends

  • 3.1.Liraglutide Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Liraglutide Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Liraglutide Market Opportunities
  • 3.4.Liraglutide Market Future Trends

4.Liraglutide Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Liraglutide Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Liraglutide Market Landscape

  • 6.1.Liraglutide Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Liraglutide Market - By Application

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 7.1.2.Diabetes Treatment
    • 7.1.3.Weight Management

8.Liraglutide Market - By Distribution

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Distribution, 2023 & 2032 (%)
    • 8.1.2.Hospital Pharmacies
    • 8.1.3.Retail Pharmacies & Drug Stores
    • 8.1.4.Online Pharmacies

9.Liraglutide Market- By Geography

  • 9.1.Introduction
    • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2.North America
    • 9.2.1.Overview
    • 9.2.2.Liraglutide Key Manufacturers in North America
    • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.5.North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.2.6.U.S.
      • 9.2.6.1.Overview
      • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.2.6.4.U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.2.7.Canada
      • 9.2.7.1.Overview
      • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.2.7.4.Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.3.Europe
    • 9.3.1.Overview
    • 9.3.2.Liraglutide Key Manufacturers in Europe
    • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.5.Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.3.6.Germany
      • 9.3.6.1.Overview
      • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.3.6.4.Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.3.7.Italy
      • 9.3.7.1.Overview
      • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.3.7.4.Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.3.8.United Kingdom
      • 9.3.8.1.Overview
      • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.3.8.4.United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.3.9.France
      • 9.3.9.1.Overview
      • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.3.9.4.France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.3.10.Russia
      • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.3.10.3.Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.3.11.Netherlands
      • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.3.11.3.Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.3.12.Sweden
      • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.3.12.3.Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.3.13.Poland
      • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.3.13.3.Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Overview
      • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.3.14.4.Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.4.Asia Pacific (APAC)
    • 9.4.1.Overview
    • 9.4.2.Liraglutide Key Manufacturers in Asia Pacific
    • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.5.Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.4.6.India
      • 9.4.6.1.Overview
      • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.4.6.4.India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.4.7.China
      • 9.4.7.1.Overview
      • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.4.7.4.China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.4.8.Japan
      • 9.4.8.1.Overview
      • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.4.8.4.Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.4.9.South Korea
      • 9.4.9.1.Overview
      • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.4.9.4.South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.4.10.Australia
      • 9.4.10.1.Overview
      • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.4.10.4.Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.4.11.Thailand
      • 9.4.11.1.Overview
      • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.4.11.4.Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.4.12.Indonesia
      • 9.4.12.1.Overview
      • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.4.12.4.Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.4.13.Philippines
      • 9.4.13.1.Overview
      • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.4.13.4.Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.4.14.Rest of APAC
      • 9.4.14.1.Overview
      • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.4.14.4.Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.5.Latin America
    • 9.5.1.Overview
    • 9.5.2.Liraglutide Key Manufacturers in Latin America
    • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.5.Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.5.6.Brazil
      • 9.5.6.1.Overview
      • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.5.6.4.Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.5.7.Mexico
      • 9.5.7.1.Overview
      • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.5.7.4.Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.5.8.Argentina
      • 9.5.8.1.Overview
      • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.5.8.4.Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.5.9.Colombia
      • 9.5.9.1.Overview
      • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.5.9.4.Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.5.10.Rest of LATAM
      • 9.5.10.1.Overview
      • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.5.10.4.Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.6.Middle East and Africa
    • 9.6.1.Overview
    • 9.6.2.Liraglutide Key Manufacturers in Middle East and Africa
    • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.5.Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.6.6.Saudi Arabia
      • 9.6.6.1.Overview
      • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.6.6.4.Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.6.7.United Arab Emirates
      • 9.6.7.1.Overview
      • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.6.7.4.United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.6.8.Israel
      • 9.6.8.1.Overview
      • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.6.8.4.Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.6.9.Turkey
      • 9.6.9.1.Overview
      • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.6.9.4.Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.6.10.Algeria
      • 9.6.10.1.Overview
      • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.6.10.4.Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.6.11.Egypt
      • 9.6.11.1.Overview
      • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.6.11.4.Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.6.12.Rest of MEA
      • 9.6.12.1.Overview
      • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.6.12.4.Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Liraglutide Industry

  • 10.1.Competitive Dashboard
  • 10.2.Company Profiles
    • 10.2.1.Bachem
    • 10.2.2.HEC Pharm
    • 10.2.3.Kingpep Biotechnology
    • 10.2.4.Shenzhen JYMed Technology
    • 10.2.5.Novo Nordisk
    • 10.2.6.Eli Lilly and Company
    • 10.2.7.Boehringer Ingelheim
    • 10.2.8.AstraZeneca
    • 10.2.9.Others

11.360 Degree Analyst View

12.Appendix

  • 12.1.Research Methodology
  • 12.2.References
  • 12.3.Abbreviations
  • 12.4.Disclaimer
  • 12.5.Contact Us